Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.

Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee. Clin Cancer Res. 2015 Nov 15; 21(22):5057-63.

View in: PubMed

subject areas

Advisory Committees
Biomedical Research
Clinical Trials as Topic
Drugs, Investigational
Endpoint Determination
Guidelines as Topic
Humans
National Cancer Institute (U.S.)
Neoplasms
United States

authors with profiles

Mark J. Ratain